Amit Sachdev Insider Trading
Get free email notifications about insider trading for Amit Sachdev.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Amit Sachdev. Amit Sachdev is a EVP, Chief Patient Officer in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and a EVP, CRO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and a EVP, Policy, Access & Value in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and a SVP, Corp Affairs & Pub Policy in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and a SVP, Public Policy,Gov Affairs in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and a Director in Eiger BioPharmaceuticals, Inc. ($EIGR).
Address: C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE 02139 MA
Companies in which Amit Sachdev is an Insider
Eiger BioPharmaceuticals, Inc.
Trading Symbol: EIGRIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Amit Sachdev: Director
Holdings: 10,000 shares
Current Value: $116,000
Latest Transaction: Mar 15 2021
$EIGR Market Capitalization: $93.59M
$EIGR Previous Close: $11.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VERTEX PHARMACEUTICALS INC / MA
Trading Symbol: VRTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Amit Sachdev: EVP, Chief Patient Officer, EVP, CRO, EVP, Policy, Access & Value, SVP, Corp Affairs & Pub Policy, SVP, Public Policy,Gov Affairs
Holdings: 44,017 shares
Current Value: $3,822,436
Latest Transaction: Apr 29 2021
$VRTX Market Capitalization: $21.78B
$VRTX Previous Close: $86.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Amit Sachdev
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 29 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 86.52 | 3,884 | 336,044 | 0 | |
Apr 29 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 217.69 | 200 | 43,538 | 40,133 | 40.3 K to 40.1 K (-0.50 %) |
Apr 29 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 216.67 | 1,338 | 289,904 | 40,333 | 41.7 K to 40.3 K (-3.21 %) |
Apr 29 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 215.58 | 2,346 | 505,751 | 41,671 | 44 K to 41.7 K (-5.33 %) |
Apr 29 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 86.52 | 3,884 | 336,044 | 44,017 | 40.1 K to 44 K (+9.68 %) |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Sachdev Amit | Director | Option Exercise | A | 9.99 | 10,000 | 99,900 | 10,000 | |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Sachdev Amit | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |